|Articles|June 15, 2008

Secondary Prevention of Noncardioembolic Ischemic Stroke
Volume 14
Issue 7 Suppl

Secondary Prevention of Noncardioembolic Ischemic Stroke

Download PDF: Secondary Prevention of Noncardioembolic Ischemic Stroke

Articles in this issue

about 18 years ago

Article

Managed Care Considerations

about 18 years ago

Article

Therapeutic Interventions for Prevention of Recurrent Ischemic Stroke

about 18 years ago

Article

Participating Faculty

about 18 years ago

Article

Introduction

about 18 years ago

Article

Stroke and TIA: Epidemiology, Risk Factors, and the Need for Early Intervention

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Secondary Prevention of Noncardioembolic Ischemic Stroke

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

FDA Approves Novel Iberdomide Regimen in RRMM

Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MD

IL-17 Signaling Bridges Psoriasis and Cardiometabolic Risk, Review Finds

AI Model Outperforms Apnea-Hypopnea Index in Predicting Sleep Apnea Mortality Risk

Topical Delgocitinib Rivals Dupilumab for Hand Eczema, but Adherence Is Key